Figure 2: Comparison of pharmacokinetic feature (Ktrans) of estrogen receptor (ER)-positive breast lesions with low and high OncotypeDX recurrence scores. | Scientific Reports

Figure 2: Comparison of pharmacokinetic feature (Ktrans) of estrogen receptor (ER)-positive breast lesions with low and high OncotypeDX recurrence scores.

From: A Radio-genomics Approach for Identifying High Risk Estrogen Receptor-positive Breast Cancers on DCE-MRI: Preliminary Results in Predicting OncotypeDX Risk Scores

Figure 2

(a) Ktrans in 47-year-old women with low OncotypeDX (=8), low grade ER-positive breast lesion, and (b) Ktrans in 54-year-old women with high OncotypeDX (=58), high grade ER-positive breast lesion. The Ktrans values are encoded in a color scale, where large values are represented in dark red and small values are represented in yellow. Note a greater heterogeneity within the high risk ER-positive breast cancers compared to low risk breast cancers.

Back to article page